Press releases
STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, today announced that it will be giving a company presentation at Bio€quity Europe 2018, Ghent, Belgium, 14 - 16 May 2018.
Read more
STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, today announced that it has won the Life Science Innovation Award at the Business Weekly Awards ceremony.
Read more
STORM Therapeutics today announced the appointment of Nobel Prize Winner Professor Thomas Cech as a Scientific Advisor. This appointment follows STORM Therapeutics’ successful Series A Financing Extension announced in January 2018.
Read more
Storm Therapuetics today announced that it has raised an additional £4 million of funding from Taiho Ventures, LLC the strategic corporate venture capital arm of Taiho Pharmaceutical Co., Ltd.
Read more
STORM Therapeutics today announced the appointment of both Professor Mark Dawson and Dr Paul Leeson to the Scientific Advisory Board.
Read more